Prime Medicine Statistics Share Statistics Prime Medicine has 178.2M
shares outstanding. The number of shares has increased by 9.38%
in one year.
Shares Outstanding 178.2M Shares Change (YoY) 9.38% Shares Change (QoQ) 0.1% Owned by Institutions (%) 45.58% Shares Floating 58.4M Failed to Deliver (FTD) Shares 35,749 FTD / Avg. Volume 0.84%
Short Selling Information The latest short interest is 18.37M, so 10.31% of the outstanding
shares have been sold short.
Short Interest 18.37M Short % of Shares Out 10.31% Short % of Float 16.94% Short Ratio (days to cover) 4.3
Valuation Ratios The PE ratio is -1.77 and the forward
PE ratio is -3.82.
Prime Medicine's PEG ratio is
0.07.
PE Ratio -1.77 Forward PE -3.82 PS Ratio 116.1 Forward PS 25.1 PB Ratio 2.26 P/FCF Ratio -2.66 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Prime Medicine.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.58,
with a Debt / Equity ratio of 0.27.
Current Ratio 5.58 Quick Ratio 5.58 Debt / Equity 0.27 Debt / EBITDA -0.21 Debt / FCF -0.31 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $13.94K Profits Per Employee $-915.34K Employee Count 214 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 4.79% in the
last 52 weeks. The beta is 2.4, so Prime Medicine's
price volatility has been higher than the market average.
Beta 2.4 52-Week Price Change 4.79% 50-Day Moving Average 3.74 200-Day Moving Average 2.62 Relative Strength Index (RSI) 54.31 Average Volume (20 Days) 4,238,514
Income Statement In the last 12 months, Prime Medicine had revenue of 2.98M
and earned -195.88M
in profits. Earnings per share was -1.65.
Revenue 2.98M Gross Profit 2.98M Operating Income -202.47M Net Income -195.88M EBITDA -196.34M EBIT -202.47M Earnings Per Share (EPS) -1.65
Full Income Statement Balance Sheet The company has 182.48M in cash and 40.79M in
debt, giving a net cash position of 141.68M.
Cash & Cash Equivalents 182.48M Total Debt 40.79M Net Cash 141.68M Retained Earnings -687.21M Total Assets 279.01M Working Capital 87.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -122.86M
and capital expenditures -7.29M, giving a free cash flow of -130.16M.
Operating Cash Flow -122.86M Capital Expenditures -7.29M Free Cash Flow -130.16M FCF Per Share -1.1
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -6787.36% and -6566.61%.
Gross Margin 100% Operating Margin -6787.36% Pretax Margin -6566.61% Profit Margin -6566.61% EBITDA Margin -6581.93% EBIT Margin -6787.36% FCF Margin -4363.36%
